ICON ROE 2010-2024 | ICLR
Current and historical return on equity (ROE) values for ICON (ICLR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ICON ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $0.75B | $9.77B | 7.86% |
| 2024-06-30 | $0.71B | $9.59B | 7.67% |
| 2024-03-31 | $0.68B | $9.43B | 7.50% |
| 2023-12-31 | $0.61B | $9.24B | 6.88% |
| 2023-09-30 | $0.51B | $8.96B | 5.89% |
| 2023-06-30 | $0.51B | $8.80B | 5.97% |
| 2023-03-31 | $0.51B | $8.65B | 6.08% |
| 2022-12-31 | $0.51B | $8.50B | 6.13% |
| 2022-09-30 | $0.46B | $8.24B | 5.71% |
| 2022-06-30 | $0.21B | $8.15B | 2.60% |
| 2022-03-31 | $0.17B | $8.07B | 2.57% |
| 2021-12-31 | $0.15B | $8.07B | 3.06% |
| 2021-09-30 | $0.18B | $7.97B | 5.17% |
| 2021-06-30 | $0.36B | $2.03B | 19.35% |
| 2021-03-31 | $0.34B | $1.93B | 19.11% |
| 2020-12-31 | $0.33B | $1.85B | 20.02% |
| 2020-09-30 | $0.33B | $1.71B | 20.49% |
| 2020-06-30 | $0.33B | $1.58B | 21.25% |
| 2020-03-31 | $0.38B | $1.51B | 24.24% |
| 2019-12-31 | $0.37B | $1.66B | 24.34% |
| 2019-09-30 | $0.36B | $1.54B | 24.85% |
| 2019-06-30 | $0.35B | $1.53B | 25.04% |
| 2019-03-31 | $0.33B | $1.42B | 24.90% |
| 2018-12-31 | $0.32B | $1.35B | 25.18% |
| 2018-09-30 | $0.31B | $1.33B | 24.63% |
| 2018-06-30 | $0.30B | $1.24B | 24.77% |
| 2018-03-31 | $0.29B | $1.21B | 25.30% |
| 2017-12-31 | $0.28B | $1.19B | 26.18% |
| 2017-09-30 | $0.28B | $1.13B | 28.06% |
| 2017-06-30 | $0.27B | $1.03B | 28.02% |
| 2017-03-31 | $0.27B | $0.95B | 28.48% |
| 2016-12-31 | $0.26B | $0.95B | 28.39% |
| 2016-09-30 | $0.25B | $0.99B | 28.73% |
| 2016-06-30 | $0.25B | $0.91B | 29.59% |
| 2016-03-31 | $0.25B | $0.84B | 28.41% |
| 2015-12-31 | $0.24B | $0.76B | 26.43% |
| 2015-09-30 | $0.23B | $0.86B | 24.10% |
| 2015-06-30 | $0.22B | $1.02B | 22.00% |
| 2015-03-31 | $0.20B | $1.00B | 20.31% |
| 2014-12-31 | $0.18B | $0.95B | 18.47% |
| 2014-09-30 | $0.16B | $1.01B | 16.49% |
| 2014-06-30 | $0.14B | $1.00B | 14.82% |
| 2014-03-31 | $0.12B | $0.96B | 13.49% |
| 2013-12-31 | $0.10B | $0.91B | 12.23% |
| 2013-09-30 | $0.09B | $0.86B | 11.32% |
| 2013-06-30 | $0.08B | $0.80B | 10.51% |
| 2013-03-31 | $0.07B | $0.77B | 9.71% |
| 2012-12-31 | $0.06B | $0.76B | 8.53% |
| 2012-09-30 | $0.04B | $0.72B | 6.32% |
| 2012-06-30 | $0.02B | $0.68B | 3.33% |
| 2012-03-31 | $0.02B | $0.70B | 3.29% |
| 2011-12-31 | $0.02B | $0.68B | 3.16% |
| 2011-09-30 | $0.04B | $0.70B | 5.77% |
| 2011-06-30 | $0.06B | $0.71B | 9.26% |
| 2011-03-31 | $0.07B | $0.69B | 11.20% |
| 2010-12-31 | $0.09B | $0.67B | 13.92% |
| 2010-09-30 | $0.10B | $0.65B | 15.99% |
| 2010-06-30 | $0.10B | $0.60B | 17.42% |
| 2010-03-31 | $0.10B | $0.59B | 17.41% |
| 2009-12-31 | $0.10B | $0.57B | 18.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.879B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.995B | 10.55 |
| Cencora (COR) | United States | $43.734B | 16.44 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $20.871B | 0.00 |
| Viatris (VTRS) | United States | $14.478B | 4.46 |
| Avantor (AVTR) | United States | $14.307B | 21.45 |
| Revvity (RVTY) | United States | $13.453B | 23.37 |
| BioMerieux (BMXMF) | France | $12.659B | 0.00 |
| CochLear (CHEOY) | Australia | $11.807B | 0.00 |
| Solventum (SOLV) | United States | $11.540B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
| Doximity (DOCS) | United States | $10.302B | 60.64 |
| Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
| HealthEquity (HQY) | United States | $8.212B | 41.20 |
| Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.759B | 20.11 |
| Organon (OGN) | United States | $3.719B | 3.75 |
| BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
| Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
| Concentras Parent (CON) | United States | $2.491B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| PACS (PACS) | United States | $1.992B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
| Progyny (PGNY) | United States | $1.208B | 24.47 |
| Embecta (EMBC) | United States | $1.161B | 8.12 |
| CareDx (CDNA) | United States | $1.102B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| SBC Medicals (SBC) | United States | $0.649B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| DocGo (DCGO) | United States | $0.444B | 16.73 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 33.48 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Biodesix (BDSX) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.156B | 8.44 |
| MultiPlan (MPLN) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 15.69 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.033B | 0.87 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |